Electroencephalographic Neonatal Seizures: Clinical Trials

2 trials for Electroencephalographic Neonatal Seizures, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1
Phase 31Terminated 1

Follow Electroencephalographic Neonatal Seizures: new trials by email Literature Review of Electroencephalographic Neonatal Seizures trials Research Report on Electroencephalographic Neonatal Seizures

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Lacosamide in Neonates With Repeated Electroencephalographic Neonatal Seizures
Lacosamide intravenous, Lacosamide oral, Active Comparator - Electroencephalographic Neonatal Seizures, Epilepsy
Phase 2TerminatedUCB Biopharma SRL292021-03-312025-10-03
A Study to Test the Pharmacokinetics, Efficacy, and Safety of Brivaracetam in Newborns With Repeated Electroencephalographic Seizures
Brivaracetam (BRV) intravenous (iv), Brivaracetam (BRV) oral - Electroencephalographic Neonatal Seizures
Phase 3TerminatedUCB Biopharma SRL92019-05-072024-04-08

Narrower conditions

Epilepsy (2)

Broader conditions

Brain Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Nervous System Diseases (2)

Interventions

Lacosamide (1)  ·  brivaracetam (1)

Sponsors

UCB Biopharma SRL (2)

Countries

Australia (1)  ·  Belgium (1)  ·  Canada (1)  ·  Czechia (1)  ·  France (1)  ·  Germany (1)  ·  Ireland (1)  ·  Italy (1)  ·  United Kingdom (1)  ·  United States (1)

Results publications

PMID 38049197

NIH funding

2015 (1)